Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „betapharm“
Suchtreffer
Begriffe & Kennungen
Azacitidine betapharm · 4.8 · Cardiac events Data from a clinical trial allowing enrolment of patients with known history of cardiovascular
Eintrag öffnenAzacitidine betapharm · 4.8 · Description of selected adverse reactions Haematologic adverse reactions The most commonly reported (≥ 10 %) h
Eintrag öffnenAzacitidine betapharm · 4.8 · Elderly population There is limited safety information available with azacitidine in patients ≥ 85 years (with
Eintrag öffnenAzacitidine betapharm · 4.8 · Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100);
Eintrag öffnenAzacitidine betapharm · 4.8 · Gastrointestinal adverse reactions The most commonly reported gastrointestinal adverse reactions associated wi
Eintrag öffnenAzacitidine betapharm · 4.8 · Hepatic adverse reactions Patients with extensive tumour burden due to metastatic disease have been reported t
Eintrag öffnenAzacitidine betapharm · 4.8 · Hypersensitivity Serious hypersensitivity reactions have been reported in patients receiving azacitidine. In c
Eintrag öffnenAzacitidine betapharm · 4.8 · In Study AZA-AML-004, 7 paediatric patients (aged 2 to 12 years) were treated with azacitidine for AML in mole
Eintrag öffnenAzacitidine betapharm · 4.8 · Infections Myelosuppression may lead to neutropenia and an increased risk of infection. Serious adverse reacti
Eintrag öffnenAzacitidine betapharm · 4.8 · No new safety signals were identified in the limited number of paediatric patients treated with azacitidine du
Eintrag öffnenAzacitidine betapharm · 4.8 · Paediatric population In Study AZA-JMML-001, 28 paediatric patients (1 month to less than 18 years of age) wer
Eintrag öffnenAzacitidine betapharm · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenAzacitidine betapharm · 4.8 · Skin and subcutaneous tissue adverse reactions The majority of skin and subcutaneous adverse reactions were as
Eintrag öffnenAzacitidine betapharm · 4.8 · Summary of the safety profile
Eintrag öffnenAzacitidine betapharm · 4.8 · System organ Very common Common Uncommon Rare Not known class Infections and pneumonia* sepsis* (including nec
Eintrag öffnenAzacitidine betapharm · 4.8 · Table 1: Adverse reactions reported in patients with MDS or AML treated with azacitidine (clinical studies and
Eintrag öffnenAzacitidine betapharm · 4.8 · Tabulated list of adverse reactions Table 1 below contains adverse reactions associated with azacitidine treat
Eintrag öffnenAzacitidine betapharm · 4.8 · The most common serious adverse reactions noted from the pivotal study (AZA PH GL 2003 CL 001) included febril
Eintrag öffnenAzacitidine betapharm · 4.8 · The most commonly reported (≥ 30 %) adverse reactions with azacitidine treatment were gastrointestinal events,
Eintrag öffnenAzacitidine betapharm · 4.8 · The most commonly reported adverse reactions with azacitidine treatment were haematological reactions (71.4 %)
Eintrag öffnen